{"Q": 1, "answer": "no", "rationale": "The segment does not contain an intensifier or comparative adjective directly modifying a risk-adjective.", "method": "llm_batch", "batch_id": "batch_1_16792", "batch_size": 260, "batch_pos": 78, "statement_text": "Moderna's mRNA vaccine research actually began with pandemic flu, and was modified for COVID, said Raffael Nachbagauer, executive director of infectious diseases at Moderna.", "article_id": 1272}
{"Q": 2, "answer": "no", "rationale": "The segment neutrally reports on the history of Moderna's research.", "method": "llm_batch", "batch_id": "batch_2_6268", "batch_size": 260, "batch_pos": 67, "statement_text": "Moderna's mRNA vaccine research actually began with pandemic flu, and was modified for COVID, said Raffael Nachbagauer, executive director of infectious diseases at Moderna.", "article_id": 1272}
{"Q": 3, "answer": "no", "rationale": "The segment discusses the history of mRNA vaccine research.", "method": "llm_batch", "batch_id": "batch_3_14884", "batch_size": 260, "batch_pos": 49, "statement_text": "Moderna's mRNA vaccine research actually began with pandemic flu, and was modified for COVID, said Raffael Nachbagauer, executive director of infectious diseases at Moderna.", "article_id": 1272}
{"Q": 4, "answer": "no", "rationale": "The segment reports factual information about research history, without posing a loaded rhetorical question.", "method": "llm_batch", "batch_id": "batch_4_15756", "batch_size": 260, "batch_pos": 47, "statement_text": "Moderna's mRNA vaccine research actually began with pandemic flu, and was modified for COVID, said Raffael Nachbagauer, executive director of infectious diseases at Moderna.", "article_id": 1272}
{"Q": 5, "answer": "no", "rationale": "The segment describes Moderna's research history, lacking explicit calming language.", "method": "llm_batch", "batch_id": "batch_5_11380", "batch_size": 260, "batch_pos": 45, "statement_text": "Moderna's mRNA vaccine research actually began with pandemic flu, and was modified for COVID, said Raffael Nachbagauer, executive director of infectious diseases at Moderna.", "article_id": 1272}
{"Q": 6, "answer": "no", "rationale": "The segment does not contain a minimiser word used in conjunction with a scale contrast.", "method": "llm_batch", "batch_id": "batch_6_13968", "batch_size": 260, "batch_pos": 29, "statement_text": "Moderna's mRNA vaccine research actually began with pandemic flu, and was modified for COVID, said Raffael Nachbagauer, executive director of infectious diseases at Moderna.", "article_id": 1272}
{"Q": 7, "answer": "no", "rationale": "The segment discusses vaccine research history but contains no bare negation.", "method": "llm_batch", "batch_id": "batch_7_11736", "batch_size": 260, "batch_pos": 26, "statement_text": "Moderna's mRNA vaccine research actually began with pandemic flu, and was modified for COVID, said Raffael Nachbagauer, executive director of infectious diseases at Moderna.", "article_id": 1272}
{"Q": 8, "answer": "no", "rationale": "The segment describes historical development, not a current capability statement.", "method": "llm_batch", "batch_id": "batch_8_9576", "batch_size": 260, "batch_pos": 248, "statement_text": "Moderna's mRNA vaccine research actually began with pandemic flu, and was modified for COVID, said Raffael Nachbagauer, executive director of infectious diseases at Moderna.", "article_id": 1272}
{"Q": 9, "answer": "no", "rationale": "The segment reports vaccine research origin, not prices, economic data, or numerical metrics in the context of Q9.", "method": "llm_batch", "batch_id": "batch_9_15524", "batch_size": 260, "batch_pos": 71, "statement_text": "Moderna's mRNA vaccine research actually began with pandemic flu, and was modified for COVID, said Raffael Nachbagauer, executive director of infectious diseases at Moderna.", "article_id": 1272}
{"Q": 10, "answer": "no", "rationale": "The segment states research began with pandemic flu but does not speculate about future relief or improvement.", "method": "llm_batch", "batch_id": "batch_10_11464", "batch_size": 260, "batch_pos": 221, "statement_text": "Moderna's mRNA vaccine research actually began with pandemic flu, and was modified for COVID, said Raffael Nachbagauer, executive director of infectious diseases at Moderna.", "article_id": 1272}
{"Q": 11, "answer": "no", "rationale": "Attributed statement reports factual research origin, not framing.", "method": "llm_batch", "batch_id": "batch_11_14760", "batch_size": 260, "batch_pos": 219, "statement_text": "Moderna's mRNA vaccine research actually began with pandemic flu, and was modified for COVID, said Raffael Nachbagauer, executive director of infectious diseases at Moderna.", "article_id": 1272}
{"Q": 12, "answer": "yes", "rationale": "Factual reporting of historical research focus presented neutrally.", "method": "llm_batch", "batch_id": "batch_12_3224", "batch_size": 260, "batch_pos": 219, "statement_text": "Moderna's mRNA vaccine research actually began with pandemic flu, and was modified for COVID, said Raffael Nachbagauer, executive director of infectious diseases at Moderna.", "article_id": 1272}
